Daniel Teixeira da Silva
Overview
Explore the profile of Daniel Teixeira da Silva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson J, Higgins D, Todd M, Robbins J, Best A, Teixeira da Silva D
Subst Use Misuse
. 2025 Feb;
60(5):684-691.
PMID: 40019899
Background: Philadelphia's opioid overdose crisis has reached unprecedented levels. However, overdose deaths involving non-opioids have also increased in recent years. As overdose deaths continue to increase, this study describes and...
2.
Herrera M, Mahajan A, Bonett S, Aronowitz S, Bauermeister J, Teixeira da Silva D
Subst Use Addctn J
. 2024 Sep;
45(4):548-558.
PMID: 39234640
Background: People with substance use disorder (SUD) are at increased risk of HIV infection. HIV testing and pre-exposure prophylaxis (PrEP) are evidence-based practices to prevent HIV infection, yet these approaches...
3.
Tomson C, Neuschatz R, Teixeira da Silva D
Nurs Outlook
. 2024 Jul;
72(5):102248.
PMID: 39067108
Xylazine-associated wounds are a distinct, novel clinical entity characterized by co-occurrence with substance use, progressive necrosis of skin, muscle, tendon, and bone, and slow healing. In Philadelphia, the specter of...
4.
Tan M, Nassau T, Kuncio D, Higgins D, Teixeira da Silva D, Tomlinson D, et al.
J Addict Med
. 2024 Jan;
18(2):194-200.
PMID: 38289240
Objectives: Xylazine is commonly mixed with illicit opioids in Philadelphia, and potential associations with wound issues, infectious diseases, and overdoses are of public health concern. We used data from the...
5.
Bonett S, Mahajan A, Teixeira da Silva D, Williams J, Brady K, Bauermeister J, et al.
Implement Sci Commun
. 2024 Jan;
5(1):4.
PMID: 38183133
Background: Pre-exposure prophylaxis (PrEP) is an effective HIV prevention method and a key component of Philadelphia's Community Plan to End the HIV Epidemic (EHE). However, significant barriers to accessing PrEP...
6.
Shearer R, Segel J, Howell B, Jones A, Khatri U, Teixeira da Silva D, et al.
Med Care
. 2024 Jan;
62(3):151-160.
PMID: 38180005
Background: As overdose deaths continue to rise, public health officials need comprehensive surveillance data to design effective prevention, harm reduction, and treatment strategies. Disparities across race and ethnicity groups, as...
7.
Teixeira da Silva D, Valente P, Lin W, Hightow-Weidman L, Mayer K, Biello K, et al.
Behav Med
. 2023 Dec;
50(4):321-329.
PMID: 38126713
Psychosocial and structural stressors and low engagement in medical care likely contribute to the disproportionate burden of chronic disease among sexual minority men (SMM) across the life course. However, how...
8.
Segel J, Shearer R, Jones A, Khatri U, Howell B, Crowley D, et al.
Subst Use Misuse
. 2023 Dec;
59(4):558-566.
PMID: 38037904
Background: As overdose rates increase for multiple substances, policymakers need to identify geographic patterns of substance-specific deaths. In this study, we describe county-level opioid and psychostimulant overdose patterns and how...
9.
Biello K, Valente P, Teixeira da Silva D, Lin W, Drab R, Hightow-Weidman L, et al.
J Int AIDS Soc
. 2023 Jul;
26 Suppl 2():e26096.
PMID: 37439061
Introduction: Pre-exposure prophylaxis (PrEP) has been available for young people for over a decade, yet only ∼15% of young people in the United States with indications for PrEP have a...
10.
Teixeira da Silva D, Makeneni S, Wall H, Bauermeister J, Wood S
Sex Transm Infect
. 2023 Mar;
99(4):272-275.
PMID: 36868813
Objectives: Engagement in guideline-recommended sexually transmitted infection (STI) care is fundamental to ending the STI epidemic in the USA. However, the US 2021-2025 STI National Strategic Plan and STI surveillance...